Expression of Bone Morphogenetic Proteins, the Subfamily of the Transforming Growth Factor-β Superfamily, in Renal Cell Carcinoma

Journal of Urology

Volumn 178, Issue 3, 2007, Pages 1062-1067

  Kwak, Cheol ^a   Park, Yong Hyun ^a   Kim, Isaac Y ^b   Moon, Kyung Chul ^a   Ku, Ja Hyeon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

bone morphogenetic proteins; carcinoma; kidney; mortality; prognosis; renal cell

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; OSTEOGENIC PROTEIN 1; STREPTAVIDIN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CLEAR CELL CARCINOMA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

BONE MORPHOGENETIC PROTEINS; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 34547692446     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.05.005     Document Type: Article

References (22)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal G., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106
2. Cohen H.T., and McGovern F.J. Renal-cell carcinoma. N Engl J Med 353 (2005) 2477
3. Ljungberg B., Alamdari F.I., Rasmuson T., and Roos G. Follow-up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy. BJU Int 84 (1999) 405
4. Coppin C., Porzsolt F., Awa A., Kumpf J., Coldman A., and Wilt T. Immunotherapy for advanced renal cell cancer. Cochrane Database Syst Rev (2005) CD001425
5. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528
6. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., et al. Recombinant human osteogenic protein-1 (OP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J Biol Chem 267 (1992) 20352
7. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10 (1996) 1580
8. Kim I.Y., Lee D.H., Lee D.K., Kim B.C., Kim H.T., Leach F.S., et al. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells. Clin Cancer Res 9 (2003) 6046
9. UICC, and International Union Against Cancer. In: Sobin L.H., and Wittekind C.H. (Eds). TNM Classification of Malignant Tumours. 6th ed. (2002), Wiley-Liss, New York 193-195
10. Fuhrman S.A., Lasky L.C., and Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (1982) 655
11. Storkel S., Eble J.N., Adlakha K., Amin M., Blute M.L., Bostwick D.G., et al., Union Internationale Contre le Cancer (UICC), American Joint Committee on Cancer (AJCC). Classification of renal cell carcinoma: Workgroup No. 1. Cancer 80 (1997) 987
12. Cui Y., Jean F., Thomas G., and Christian J.L. BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development. EMBO J 17 (1998) 4735
13. Massague J., and Chen Y.G. Controlling TGF-beta signaling. Genes Dev 14 (2000) 627
14. Hay E., Lemonnier J., Fromigue O., and Marie P.J. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276 (2001) 29028
15. Langenfeld E.M., Calvano S.E., Abou-Nukta F., Lowry S.F., Amenta P., and Langenfeld J. The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24 (2003) 1445
16. Ghosh-Choudhury N., Ghosh-Choudhury G., Celeste A., Ghosh P.M., Moyer M., Abboud S.L., et al. Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. Biochim Biophys Acta 1497 (2000) 186
17. Franzen A., and Heldin N.E. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21(CIP1) and p27(KIP1). Biochem Biophys Res Commun 285 (2001) 773
18. Baade Ro T., Utne Holt R., Brenne A.T., Hjorth-Hansen H., Waage A., Hjertner O., et al. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 23 (2004) 3024
19. Schwalbe M., Sanger J., Eggers R., Naumann A., Schmidt A., Hoffken K., et al. Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol 23 (2003) 89
20. Bobinac D., Maric I., Zoricic S., Spanjol J., Dordevic G., Mustac E., et al. Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46 (2005) 389
21. Ide H., Yoshida T., Matsumoto N., Aoki K., Osada Y., Sugimura T., et al. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 57 (1997) 5022
22. Brubaker K.D., Corey E., Brown L.G., and Vessella R.L. Bone morphogenetic protein signaling in prostate cancer cell lines. J Cell Biochem 91 (2004) 151